James Robl
Executive Chairman · Immuno Cancer Biotherapeutics, Inc. · Canton, SD, United States
Biotechnology · Founded 2024
Latest raise
$75K
Date raised
October 15, 2026
Round
—
Founded2024
About James Robl
- Who is James Robl?
- James Robl is listed as Executive Chairman at Immuno Cancer Biotherapeutics, Inc., a biotechnology company founded in 2024 based in Canton, SD, United States.
- How much did Immuno Cancer Biotherapeutics, Inc. raise?
- Immuno Cancer Biotherapeutics, Inc. raised $75K on October 15, 2026 (18 days ago).
Get newly funded founders every week
A free weekly list of startups that just raised.